Table 2.
Adjusted odds ratios of variables and interaction terms for the logistic regression models of acute kidney injury, acute kidney recovery and mortality.
Adjusted Odds Ratio (95% Confidence Interval) | |||
---|---|---|---|
AKI | AKR | Mortality | |
Glucose (per increase of 100 mg/dL) | 1.48 (1.33, 1.65) | 1.27 (1.17, 1.38) | 1.76 (1.59, 1.95) |
Secondary effects | |||
Age (per increase of 1 year) | 1.01 (1.01, 1.01) | 0.97 (0.97, 0.97) | 1.05 (1.04, 1.05) |
Blood urea nitrogen (per increase of 1 mg/dL) | 1.00 (1.00, 1.10) | 1.01 (1.01, 1.01) | 1.02 (1.02, 1.02) |
Diabetes | 1.40 (1.20, 1.63) | 1.20 (1.06, 1.35) | 1.55 (1.33, 1.81) |
Heart failure | 1.18 (1.07, 1.29) | 0.82 (0.75, 0.90) | 0.81 (0.72, 0.91) |
Hypertension | 1.01 (0.93, 1.10) | 1.11 (1.03, 1.20) | 1.00 (0.92, 1.10) |
Ischemic heart disease | 1.05 (0.97, 1.12) | 0.86 (0.81, 0.91) | 0.78 (0.72, 0.84) |
Systolic blood pressure (per increase of 10 mmHg) | 1.04 (1.03, 1.05) | 0.89 (0.89, 0.90) | 0.92 (0.91, 0.93) |
Temperature (per increase of 1 C) | 0.92 (0.88, 0.95) | 1.21 (1.17, 1.25) | 0.92 (0.89, 0.96) |
Hemoglobin (per increase of 1 g/dL) | 0.96 (0.95, 0.98) | 1.08 (1.07, 1.09) | 0.92 (0.91, 0.93) |
eGFR (per increase of 30 mL/min/1.73 m2) | 0.87 (0.81, 0.93) | 0.19 (0.18, 0.20) | 1.10 (1.02, 1.18) |
Insulin | 1.45 (1.33, 1.57) | 0.71 (0.66, 0.77) | 1.30 (1.19, 1.42) |
RAAS inhibitors | 0.81 (0.76, 0.86) | 0.87 (0.83, 0.92) | 0.53 (0.50, 0.57) |
Loops diuretics | 2.43 (2.28, 2.58) | 0.56 (0.53, 0.6) | 1.77 (1.66, 1.89) |
Fluids | 1.32 (1.25, 1.40) | 1.84 (1.76, 1.93) | 2.22 (2.08, 2.38) |
Contrast administration | 1.08 (0.99, 1.18) | 1.58 (1.48, 1.68) | 1.54 (1.42, 1.68) |
Surgery | 1.58 (1.47, 1.70) | 1.13 (1.06, 1.21) | 0.61 (0.56, 0.68) |
Interaction Terms | |||
Diabetes–glucose | 0.78 (0.72, 0.86) | 0.81 (0.76, 0.87) | 0.62 (0.57, 0.67) |
eGFR–glucose | 0.88 (0.85, 0.92) | 1.20 (1.16, 1.24) | 1.04 (1.00, 1.08) |
AKI, acute kidney injury; AKR, acute kidney recovery; eGFR, estimated glomerular filtration ratio; RAAS, renin–angiotensin–aldosterone system.